Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year

Transplantation

Volumn 94, Issue 11, 2012, Pages 1117-1123

  Wojciechowski, David ^a   Chanda, Ranjan ^b   Chandran, Sindhu ^a   Lee, Brian ^a   Webber, Allison ^a   MacAraig, Melanie ^a   Tomlanovich, Stephen ^a   Vincenti, Flavio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Nephrology Associates   (United States)

Author keywords

BK virus; Ciprofloxacin; Fluoroquinolones; Kidney transplant

Indexed keywords

CIPROFLOXACIN; IMMUNOGLOBULIN;

ACUTE GRAFT REJECTION; ADULT; ANTIVIRAL RESISTANCE; ARTICLE; BK VIRUS; BK VIRUS INFECTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY INFECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TENDINITIS; TENDON RUPTURE; TREATMENT DURATION; TREATMENT OUTCOME; VIREMIA;

ADULT; AGED; ANTI-INFECTIVE AGENTS; BK VIRUS; CHI-SQUARE DISTRIBUTION; CIPROFLOXACIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SAN FRANCISCO; TIME FACTORS; TREATMENT OUTCOME; TUMOR VIRUS INFECTIONS;

EID: 84871610259     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31826ec74e     Document Type: Article

References (18)

1. Gardner SD, MacKenzie EF, Smith C, et al. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 1984; 37: 578.
2. Hogan TF, Borden EC, McBain JA, et al. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 1980; 92: 373.
3. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611.
4. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488.
5. Nickeleit V, Hirsch HH, Zeiler M, et al. BK-virus nephropathy in renal transplantsVtubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15: 324.
6. Ramos E, Drachenberg CB, Portocarrero M, et al. BK virus ne-phropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. Clin Transpl 2002; 143.
7. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582.
8. Koukoulaki M, Grispou E, Pistolas D, et al. Prospective monitoring of BK virus replication in renal transplant recipients. Transpl Infect Dis 2009; 11: 1.
9. Saad ER, Bresnahan BA, Cohen EP, et al. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation 2008; 85: 850.
10. Hilton R, Tong CY. Antiviral therapy for polyomavirus-associated nephropathy after renal transplantation. J Antimicrob Chemother 2008; 62: 855.
11. Rinaldo CH, Hirsch HH. Antivirals for the treatment of polyomavirus BK replication. Expert Rev Anti Infect Ther 2007; 5: 105.
12. Portolani M, Pietrosemoli P, Cermelli C, et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Res 1988; 9: 205.
13. Leung AY, Chan MT, Yuen KY, et al. Ciprofloxacin decreased poly-oma BK virus load in patients who underwent allogeneic hemato-poietic stem cell transplantation. Clin Infect Dis 2005; 40: 528.
14. Miller AN, Glode A, Hogan KR, et al. Efficacy and safety of cipro-floxacin for prophylaxis of polyomavirus BK virus-associated hem-orrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 2011; 17: 1176.
15. Randhawa PS. Anti-BK virus activity of ciprofloxacin and related antibiotics. Clin Infect Dis 2005; 41: 1366; author reply 1367.
16. Gabardi S, Waikar SS, Martin S, et al. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol 2010; 5: 1298.
17. Koukoulaki M, Apostolou T, Hadjiconstantinou V, et al. Impact of prophylactic administration of ciprofloxacin on BK polyoma virus replication. Transpl Infect Dis 2008; 10: 449.
18. Dall A, Hariharan S. BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol 2008; S68.